The Gillett Health Podcast BPC-157 101
17 snips
Feb 2, 2026 A clear primer on BPC-157 origins, biology, and why clinicians care. Animal and early human studies on tendon, muscle, and knee healing are discussed. Safety signals, potential risks like VEGF-related concerns, and reported side effects are reviewed. Practical talk on best use cases, sourcing options, and cost considerations for clinical use.
AI Snips
Chapters
Transcript
Episode notes
BPC-157 Is Bioidentical And Orally Active
- BPC-157 is a bioidentical peptide derived from gastric juice and has human clinical data supporting its effects.
- Its origin explains oral stability and biological relevance compared to many research chemicals.
Rodent Study Shows Faster Tendon-Muscle Healing
- The pair described rodent studies where oral BPC-157 in drinking water sped healing after muscle-tendon injury.
- They contrasted the treated group with control animals to highlight visible healing differences.
VEGF Upregulation Explains Tissue Repair Effects
- BPC-157 upregulates VEGF, making it mechanistically similar to therapies that increase local blood flow like PRP.
- That VEGF effect helps explain benefits for joints and connective tissue but raises safety considerations.